12 completed, 3 unknown. 3 Phase 1, 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Not applicable | 1 | Unknown 1 |
Follow Gene Rearrangement: new trials by email Literature Review of Gene Rearrangement trials Research Report on Gene Rearrangement
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia gene expression analysis, gene rearrangement analysis, polymerase chain reaction - Leukemia | Completed | Children's Oncology Group | 20 | 2011-12-01 | 2016-05-18 | |
| Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer DNA analysis, cytogenetic analysis, gene expression analysis - Brain and Central Nervous System Tumors, Hereditary Wilms Tumor | Completed | Children's Oncology Group | 31 | 2011-05-01 | 2016-07-11 | |
| Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia DNA analysis, gene rearrangement analysis, microarray analysis - Leukemia | Completed | Children's Oncology Group | 9 | 2011-02-01 | 2016-05-18 | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma DNA analysis, RNA analysis, gene expression analysis - Sarcoma | Completed | Children's Oncology Group | 99 | 2010-01-01 | 2015-05-06 | |
| GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma rituximab, sargramostim, cyclophosphamide - Lymphoma | Phase 2 | Unknown | French Innovative Leukemia Organisation | 30 | 2009-03-01 | 2013-08-02 |
| GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma rituximab, sargramostim, gene expression analysis - Lymphoma | Phase 2 | Unknown | French Innovative Leukemia Organisation | 60 | 2009-03-01 | 2013-08-02 |
| Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers 3T MR Imaging, C-Choline PET Scanning, Gene Rearrangement - Prostate Cancer | Phase 1 | Completed | AHS Cancer Control Alberta | 26 | 2008-11-01 | 2016-07-06 |
| Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma therapeutic autologous lymphocytes, cyclophosphamide, aldesleukin - B-cell Chronic Lymphocytic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Phase 1 | Completed | Fred Hutchinson Cancer Center | 12 | 2007-08-01 | 2014-08-06 |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer gene expression analysis, gene rearrangement analysis, polymorphism analysis - Breast Cancer, Cervical Cancer | Not applicable | Unknown | The Christie NHS Foundation Trust | 2200 | 2006-03-01 | 2013-08-26 |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer filgrastim, pegfilgrastim, rituximab - Leukemia, Lymphoma | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 50 | 2005-07-01 | 2016-05-12 |
| Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma gene rearrangement analysis, polymerase chain reaction, proteomic profiling - Lymphoma | Completed | National Institutes of Health Clinical Center (CC) | 100 | 2004-01-01 | 2012-03-15 | |
| Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma comparative genomic hybridization, cytogenetic analysis, fluorescence in situ hybridization - Lymphoma | Completed | Alliance for Clinical Trials in Oncology | 391 | 1999-06-01 | 2016-07-06 | |
| Genetic Study of Patients and Families With a History of Colorectal Cancer DNA stability analysis, gene rearrangement analysis - Colorectal Cancer | Completed | Alliance for Clinical Trials in Oncology | 1500 | 1998-07-01 | 2016-07-04 | |
| Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor chromosomal translocation analysis, gene rearrangement analysis, mutation analysis - Brain and Central Nervous System Tumors, Lymphoma | Completed | Duke University | 19 | 1997-01-01 | 2015-10-15 | |
| DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Southern blotting, chromosomal translocation analysis, cytogenetic analysis - Leukemia | Completed | Children's Oncology Group | 149 | 1997-01-01 | 2017-04-26 |
Lymphoma (6) · Leukemia (4) · Lymphoma, Follicular (4) · Lymphoma, Mantle-Cell (3) · Sarcoma (3) · Central Nervous System Neoplasms (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Medulloblastoma (2) · Prostatic Neoplasms (2) · Waldenstrom Macroglobulinemia (2) · Astrocytoma (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Burkitt Lymphoma (1)
Children's Oncology Group (5) · Alliance for Clinical Trials in Oncology (2) · French Innovative Leukemia Organisation (2) · AHS Cancer Control Alberta (1) · Duke University (1) · Fred Hutchinson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · National Institutes of Health Clinical Center (CC) (1) · The Christie NHS Foundation Trust (1)
United States (6) · Canada (2) · United Kingdom (1)
Jean-Francois Rossi, MD, PhD (2) · Andrew D. Zelenetz, MD, PhD (1) · Beverly J. Lange, MD (1) · Brian Till (1) · Carolyn A. Felix, MD (1) · Catherine West (1) · Dana A. Hill, MD (1) · Edward C. Halperin, MD (1) · Eric Guest, MD (1) · Javed Khan, MD (1) · Julie D. Saba, MD, PhD (1) · Mark C. Udey, MD, PhD (1) · Nawaid Usmani, MD, FRCPC (1) · Noralane M. Lindor, MD (1) · Raju Chaganti, PhD (1)
U10CA076001 (1)